Sojourn Therapeutics Limited

16591284

active

ltd

england wales

Companies House

Health Score

65 / 100

Some Concerns

25/30

Filing

0/30

Financial

40/40

Risk

No risk factors detected.

Details

167-169 Great Portland Street, 5th Floor, London, W1W 5PF

Incorporated 18/07/2025

Compliance

Next accounts due

18/04/2027

On track

Confirmation statement

Last: 17/07/2026

Due 31/07/2027

On track

Industry

72110

Research and experimental development on biotechnology

Officers

Samuel Cohen

director · Since 18/07/2025

DIRECTOR

BRITISH · ENGLAND · Age 39

Joseph John Wilson

secretary · Since 18/07/2025

Professor Tuomas Pertti Jonathan Knowles

director · Since 18/07/2025

DIRECTOR

BRITISH · ENGLAND · Age 47

Also on 3 other boards

Mr George Kelly Martin

director · Since 18/07/2025

DIRECTOR

AMERICAN · UNITED STATES · Age 67

Also on 3 other boards

Joseph John Wilson

secretary · Since 18/07/2025

Samuel Cohen

director · Since 18/07/2025

British · England · Age 40

Tuomas Pertti Jonathan Knowles

director · Since 18/07/2025

British · England · Age 47

George Kelly Martin

director · Since 18/07/2025

American · United States · Age 67

Persons with Significant Control

Samuel Cohen

25–50% shares

25–50% votes

British · England · Age 39

167-169, Great Portland Street, London, W1W 5PF

Notified 18/07/2025

Professor Tuomas Pertti Jonathan Knowles

25–50% shares

25–50% votes

British · England · Age 47

167-169, Great Portland Street, London, W1W 5PF

Notified 18/07/2025

Mr George Kelly Martin

Significant control

American · United States · Age 67

523, Harbor Road, Southport, 06890

Notified 18/07/2025

Change History

status → active

2026-07-07

Active

type → ltd

2026-07-07

Private Limited Company

address line1 → 167-169 Great Portland Street

2026-07-07

167-169 GREAT PORTLAND STREET

post town → London

2026-07-07

LONDON